List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 32 studies with search of: acetic acid
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: dimethylxanthenone acetic acid
2 Recruiting Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Condition: Adrenocortical Carcinoma
Intervention: Drug: R-(-)-gossypol acetic acid
3 Active, not recruiting Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein
Condition: Cholesterol, HDL
Interventions: Dietary Supplement: Vinegar;   Other: Placebo
4 Completed Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: R-(-)-gossypol acetic acid;   Drug: temozolomide;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: adjuvant therapy;   Radiation: radiation therapy
5 Active, not recruiting Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: R-(-)-gossypol acetic acid;   Genetic: protein expression analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
6 Recruiting Gossypol in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: R-(-)-gossypol acetic acid;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study
7 Recruiting Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: R-(-)-gossypol acetic acid;   Drug: bicalutamide;   Drug: releasing hormone agonist therapy;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
8 Recruiting Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: R-(-)-gossypol acetic acid;   Drug: carboplatin;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
9 Recruiting Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: R-(-)-gossypol acetic acid;   Drug: cisplatin;   Drug: etoposide
10 Completed Study of DMXAA (Now Known as ASA404) in Solid Tumors
Condition: Solid Tumors
Intervention: Drug: DMXAA
11 Recruiting Efficacy of TCA Effect on Varicella Atrophic Scars
Condition: Atrophic Varicella Scar
Intervention: Drug: 70% trichloroacetic acid
12 Completed Phase I Safety Study of DMXAA in Refractory Tumors
Condition: Refractory Tumors
Intervention: Drug: DMXAA
13 Completed Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes
Condition: Haemodialysis
Interventions: Other: Citrate dialysate;   Other: Acetate dialysate
14 Terminated
Has Results 		Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device
Condition: Cervical Neoplasia
Intervention: Procedure: Multi-spectral Digital Colposcopy (MDC)
15 Completed A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: AT-101
16 Completed Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies
Conditions: Follicular Lymphoma;   Diffuse Large Cell Lymphoma;   Mantle Cell Lymphoma;   Small Lymphocytic Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Drug: AT-101
17 Active, not recruiting A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: AT-101 and docetaxel;   Drug: placebo and docetaxel
18 Recruiting Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Condition: Lung Cancer
Intervention: Drug: oral erlotinib and pulsed doses of oral AT-101
19 Not yet recruiting Study of Lenalidomide in Combination With AT-101for Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Intervention: Drug: lenalidomide with AT-101
20 Active, not recruiting A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Condition: Hormone Refractory Prostate Cancer
Interventions: Drug: AT-101, prednisone and docetaxel;   Drug: placebo, prednisone and docetaxel

Previous Page Studies Shown (1-20) Next Page (21-32)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services